SCD and neoplasm: To monitor the anti-tumor effect of SCD1 inhibitors (iSCD1-A939572) in vivo, lung tumor-bearing mice (TetO-EGFRL858R; CCSP-rtTA) were treated with vehicle or A939572 starting at 3.5 months after doxycycline was administered (Figure 6A).